Clinical Trials in Maryland

Showing 11661-11680 of 19,983 trials

A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

NCT03724981

In this study participants will try out two different types of drug injection pens (dulaglutide and semaglutide) on a practice pad and decide which device they prefer. No study drug will be administered.

Diabetes Mellitus, Type 2

Eli Lilly and Company312 participantsStarted Oct 2018

Fresno, California, United States • Long Beach, California, United States • Palm Harbor, Florida, United States +11 more locations

COMPLETEDPhase 317 miles

Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)

NCT00405704

In this 2-year, multisite, randomized, placebo-controlled trial involving 607 children with vesicoureteral reflux that was diagnosed after a first or second febrile or symptomatic urinary tract infecton, we evaluated the efficacy of Trimethoprim-Sulfamethoxazole (TMP-SMZ) prophylaxis in preventing recurrences (primary outcome). Secondary outcomes were renal scarring, treatment failure (a composite of recurrences and scarring), and antimicrobial resistance.

Vesicoureteral RefluxUrinary Tract Infections

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)607 participantsStarted May 2007

Birmingham, Alabama, United States • Wilmington, Delaware, United States • Washington D.C., District of Columbia, United States +16 more locations

A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)

Find Trials by Condition in Maryland

Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis

A Comparison of Narrow Band Imaging (NBI) and Standard White Light Laparoscopy to Detect Endometriosis

Biomarker Development in Sturge-Weber Syndrome

An Observational Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic Osteoarthritis

Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis

Proton Radiotherapy for Recurrent Tumors

Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC

Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy

Comparative Analysis of PCM With ROTEM in the Measurement of Viscoelastic Coagulation Parameters

USS Virginia Closed-Loop for Overnight Control in Type 1 Diabetes

A Study of RO6958688 in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen Positive Solid Tumors

Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact

An Open-Label Study of a Novel JAK-inhibitor, INCB052793, Given to Patients With Advanced Malignancies

A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH)

Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme

Efficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Deficiency

A Study of Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)

Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS)